Kingdom ensures health, safety for Hajj pilgrims
These efforts are being carried out under government directives, reflecting its commitment to serving pilgrims and ensuring their comfort and safety, the Saudi Press Agency reported.
The authority will monitor and inspect products under its supervision at air, land, and sea ports of entry for pilgrims, the SPA added.
It will also oversee food and pharmaceutical facilities and medical sites in Makkah and Madinah, as well as seasonal medical facilities affiliated with Hajj affairs offices, in coordination with the Ministry of Health.
In addition, the authority will monitor products arriving via air freight from Hajj affairs offices at King Abdulaziz International Airport in Jeddah and Prince Mohammad bin Abdulaziz International Airport in Madinah.
Its initiatives during the Hajj season include field studies and awareness workshops for staff in approved food preparation kitchens to ensure compliance with health standards to provide safe meals to pilgrims, in collaboration with the municipalities of Makkah and Madinah.
The authority will also deliver multilingual awareness messages and informational programs to pilgrims on food and drug safety, according to the SPA.
The initiatives reflect the authority's ongoing efforts to deliver optimal regulatory services, enhance coordination with government agencies for a successful Hajj season, and reinforce the Kingdom's leadership in crowd management.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
2 days ago
- Arab News
Saudi health minister begins visit to Australia
SYDNEY: Saudi Minister of Health Fahad Al-Jalajel on Thursday began a visit to Australia that will include stops in Melbourne, Canberra and Sydney. A series of meetings is scheduled to take place to discuss ways of bilateral cooperation in health, innovation and health investment, tha Saudi Press Agency reported. The visit includes meetings with senior Australian officials to discuss bilateral cooperation in public health and healthcare digital transformation, explore investment opportunities, and expand partnerships between the health institutions of both countries. The trip includes visits to healthcare facilities and specialized research centers, where Al-Jalajel will meet leaders in the health and biology sectors to review advanced experiences and expertise exchange, and explore cooperation horizons in innovation, health technologies, medical coding and ambulatory services. The health minister will also meet with Saudi scholarship students in the healthcare field.
Leaders
3 days ago
- Leaders
Makkah Health Cluster Hosts International Workshop on Patient Empowerment
The Makkah Health Cluster has launched a two-day international workshop dedicated to advancing patient empowerment, bringing together leading local and global experts in the field. The event is designed to strengthen patients' roles as active partners in healthcare, improve service quality, enhance patient safety, and promote personal health awareness—while highlighting the importance of prevention before treatment. During the workshop, participants will explore international best practices in patient-centered care and discuss innovative strategies to increase patient involvement in medical decision-making. According to the cluster, this initiative aligns with the Health Sector Transformation Program—one of the key pillars of Saudi Arabia's Vision 2030—by fostering safer, more effective healthcare services for all. Related Topics: Health Minister Reviews Major Healthcare Projects in Madinah Saudi Health Offers 1.3 mln Medical Services, Reduces Heat Stress in Hajj 2024 Medina Health Cluster Launches Initiative to Raise Awareness of Heat Stress National Guard Health Prepares Medical Clinics, Sunstroke Center for Hajj 2024 Short link : Post Views: 20 Related Stories
Leaders
5 days ago
- Leaders
SFDA Approves Elrexfio for Multiple Myeloma Treatment
The Saudi Food and Drug Authority (SFDA) has approved the registration of Elrexfio (Elranatamab) for adult patients with relapsed or refractory multiple myeloma who have undergone at least four prior lines of therapy. These previous treatments must have included a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. Elrexfio has been granted orphan drug designation under the SFDA Orphan Drug Designation Program. How Elrexfio Works? Elrexfio contains Elranatamab, a bispecific antibody designed to target: BCMA – a protein found on multiple myeloma cells CD3 – a receptor on T-cells By binding to both targets, Elrexfio activates T-cells to release immune signals (cytokines) and directly destroy malignant myeloma cells. SFDA's decision followed a thorough evaluation of Elrexfio's efficacy, safety, and quality according to regulatory standards. Clinical trial data showed: 58% overall response rate in patients with relapsed or refractory multiple myeloma after at least four prior lines of therapy 82% of responders maintained their response for at least nine months Dosage, Administration Elrexfio is administered as a subcutaneous injection: Three step-up doses in the first week Once-weekly dosing up to Week 24 Once every two weeks thereafter Safety Profile The most common side effects observed in clinical studies included: Cytokine release syndrome (CRS) Injection site reactions Respiratory tract infections Musculoskeletal pain Fatigue Diarrhea Commitment to Rare Disease Treatment This approval reflects SFDA's commitment to improving access to therapies for rare and hard-to-treat conditions through the Orphan Drug Designation Program. In Saudi Arabia, a rare disease is defined as affecting fewer than 5 people per 10,000 in the population. For more details about the Orphan Drugs Guideline, visit: SFDA Orphan Drugs Guideline Or contact SFDA at: [email protected] Related Topics : SFDA Reports Record 82% Surge in Licensed Factories, Warehouses in 2024 Is wheat harmful to the intestine? SFDA clarifies the truth New Corona vaccines to arrive at the Kingdom: SFDA SFDA: National Biotechnology Strategy Highlights Saudi Leadership in Medical Innovation Short link : Post Views: 7 Related Stories
